Press Releases

All Releases
AngioDynamics to Acquire Vortex Medical
Oct 08, 2012

Strengthens Peripheral Vascular Product Portfolio and Advances Venous Disease Strategy

AngioDynamics Awarded GPO Contract for Vascular Access Products
Oct 05, 2012

Contract With HealthTrust Covers Chronic & Acute Dialysis Catheters

AngioDynamics Awarded $16.5 Million Judgment in Case Against biolitec Inc.
Oct 04, 2012
ALBANY, N.Y. , Oct. 4, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced a recent court action in its legal case against biolitec Inc.
AngioDynamics Bolsters Senior Leadership Team With Key Appointments
Sep 27, 2012
ALBANY, N.Y. , Sept. 27, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the appointment of Louis J.
AngioDynamics to Report Fiscal 2013 First Quarter Financial Results and Hold Conference Call on October 8, 2012
Sep 21, 2012
ALBANY, N.Y. , Sept. 21, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report its fiscal 2013 first quarter financial
AngioDynamics to Present at the 10th Annual CL King Best Ideas Conference
Sep 05, 2012
ALBANY, N.Y. , Sept. 5, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the 10th Annual CL King Best Ideas Conference at the
AngioDynamics Earns FDA Clearance for First Vascular Access Product With BioFlo Technology to Reduce Catheter-Related Thrombus
Aug 29, 2012
ALBANY, N.Y. , Aug. 29, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the U.S. Food and Drug Administration has granted 510(k)
AngioDynamics to Present at the 32nd Annual Canaccord Growth Conference
Aug 09, 2012
ALBANY, N.Y. , Aug. 9, 2012 (GLOBE NEWSWIRE) -- Angiodynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the 32 nd Annual Canaccord Growth Conference at the
AngioDynamics, Inc. [ANGO] to Ring The NASDAQ Stock Market Closing Bell
Jul 13, 2012
ADVISORY, July 13, 2012 (GLOBE NEWSWIRE) -- What: AngioDynamics [ANGO], a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, will visit the NASDAQ MarketSite in Times Square .
AngioDynamics Reports Fiscal 2012 Fourth Quarter and Full Year Financial Results
Jul 12, 2012
Net sales of $57.7 million with Navilyst Medical contributing $4.8 million GAAP net loss of $7.0 million , or $0.27 per share; adjusted (Non-GAAP) net income of $2.6 million , or $0.10 per share, including $0.01 from Navilyst Medical Integration of Navilyst Medical is progressing on schedule
AngioDynamics to Report Fiscal 2012 Fourth Quarter and Full Year Financial Results and Hold Conference Call on July 12, 2012
Jul 03, 2012
ALBANY, N.Y. , July 3, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report its fiscal 2012 fourth quarter and full year
Journal of the American College of Surgeons Publishes Study on Using the NanoKnife(R) System to Treat Liver Tumors Adjacent to Blood Vessels
Jul 02, 2012
ALBANY, N.Y. , July 2, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced the publication of a study in the Journal of the American College of
AngioDynamics Completes Acquisition of Navilyst Medical
May 22, 2012
ALBANY, N.Y. , May 22, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced it has completed its acquisition of Navilyst Medical .
AngioDynamics Appoints Experienced Industry Executive as Chief Technology Officer
May 21, 2012
ALBANY, N.Y. , May 21, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the appointment of George W.
AngioDynamics Shareholders Approve Share Issuance for Navilyst Medical Acquisition
May 15, 2012
ALBANY, N.Y. , May 15, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the Company's shareholders approved the issuance of approximately
AngioDynamics Resumes NanoKnife(R) System Shipments in the U.S.
Apr 23, 2012
ALBANY, N.Y. , April 23, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the resumption of shipments of its NanoKnife ® System in
AngioDynamics Reports Fiscal 2012 Third Quarter Financial Results
Apr 04, 2012
ALBANY, N.Y. , April 4, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported financial results for the fiscal 2012 third quarter and nine
NanoKnife® System Clinical Experience Featured at Society of Surgical Oncology Conference
Apr 02, 2012
ALBANY, N.Y. --(BUSINESS WIRE)-- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced presentations on NanoKnife ® System clinical experience were given at the
Five Oral Presentations on Clinical Experience With NanoKnife® System Featured at Society of Interventional Radiology Conference
Mar 29, 2012
ALBANY, N.Y. --(BUSINESS WIRE)-- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced oral presentations on NanoKnife ® System clinical experience took place at the
AngioDynamics Establishes Strategic Relationship with Microsulis Medical Ltd.
Mar 26, 2012
Exclusive International Distribution Rights for Leading Microwave Ablation Products Equity Investment with Exclusive Option to Purchase Technology ALBANY, N.Y. & DENMEAD, England --(BUSINESS WIRE)-- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices
Displaying 161 - 180 of 623

Copyright West LLC. Minimum 15 minutes delayed.